最近，富達國際發表了一份新報告，與我們的粉絲同步。
主要要點
▪ 管理層對於2022年的投資信心仍然看好，這是基於疫苗的推廣
▪ Strengthened balance sheets face the test of rising funding costs
▪ Geopolitical risks tick higher, weighing on investment plans
A year on from the shot in the arm provided by the arrival of vaccines, overall, companies
are entering 2022 in ...